NXTC

NASDAQStock

NextCure, Inc.

$13.03-0.49 (-3.66%)

52-Week Range

$3.24

$14.27

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.55

Volume

21.6K

Avg Volume

42.9K

Performance

+2.11%

+17.87%

+145.82%

YTD

+1.81%

+63.55%

-28.24%

-91.05%

Price Chart

ETF Exposure

NXTC is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.16%	2,883	$21K	$13.0M	—
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	822	$11K	$2.68B	0.14%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	3	$52	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	127	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$9	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	72,676	$789K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	382	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	32	$484	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	26,409	$287K	$84.10B	0.05%

About NXTC ETF Exposure

NextCure, Inc. (NXTC) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $13.03. Investors can gain exposure to NXTC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NXTC, sorted by portfolio weight.